Free Trial

Coya Therapeutics (COYA) Earnings Date, Estimates & Call Transcripts

Coya Therapeutics logo
$4.71 -0.10 (-2.08%)
As of 04:00 PM Eastern

Coya Therapeutics Earnings Summary

Coya Therapeutics released Q1 2026 earnings on May 12, 2026, reporting an EPS of -$0.32, which beat the consensus estimate of -$0.39 by $0.07. Quarterly revenue was reported to be $0.25 million, above analysts' expectations of $0.15 million. With a trailing EPS of -$1.15, Coya Therapeutics' earnings are expected to decrease next year, from ($1.50) to ($1.66) per share.

Upcoming Q2
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(May. 12)
-$0.39
Actual EPS
(May. 12)
-$0.32 Beat By $0.07
Actual Revenue
(May. 12)
$0.25M

Q1 2026 Earnings Resources

COYA Upcoming Earnings

Coya Therapeutics' next earnings date is estimated for Tuesday, August 11, 2026, based on past reporting schedules.

Get Coya Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coya Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

COYA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

COYA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Coya Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.39-$0.39-$0.39
Q2 20261-$0.36-$0.36-$0.36
Q3 20261-$0.40-$0.40-$0.40
Q4 20261-$0.44-$0.44-$0.44
FY 2026 4 -$1.59 -$1.59 -$1.59
Q1 20271-$0.46-$0.46-$0.46
Q2 20271-$0.46-$0.46-$0.46
Q3 20271-$0.39-$0.39-$0.39
Q4 20271-$0.35-$0.35-$0.35

Coya Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)
--------
5/12/2026Q1 2026-$0.39-$0.32+$0.07-$0.32$0.15M$0.25M
3/16/2026Q4 2025-$0.08-$0.34 -$0.26-$0.34$1.93M$3.96M
11/12/2025Q3 2025$0.02-$0.10 -$0.12-$0.13$3.70M$3.56M
8/12/2025Q2 2025-$0.22-$0.36 -$0.14-$0.36$0.78M$0.16M
5/13/2025Q1 2025-$0.44-$0.44--$0.44$2.63M$257.88M
3/18/2025Q4 2024-$0.32-$0.18+$0.14-$0.18$0.10M$0.20M
11/6/2024--$0.41-$0.26+$0.15-$0.26$0.30M-
8/12/2024Q2 2024--$0.19--$0.19-$3.43M

Data powered by Fiscal.ai.

Coya Therapeutics Earnings - Frequently Asked Questions

Coya Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on COYA's earnings history.

In the previous quarter, Coya Therapeutics (NASDAQ:COYA) reported ($0.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.39) by $0.07. Learn more on analysts' earnings estimate vs. COYA's actual earnings.

Coya Therapeutics (NASDAQ:COYA) has a recorded annual revenue of $7.95 million.

Coya Therapeutics (NASDAQ:COYA) has a recorded net income of -$21.23 million. COYA has generated -$1.15 earnings per share over the last four quarters.

Coya Therapeutics' earnings are expected to decrease from ($1.50) per share to ($1.66) per share in the next year.


This page (NASDAQ:COYA) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners